305 related articles for article (PubMed ID: 6400672)
21. Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
Hansen HP; Rossing P; Tarnow L; Nielsen FS; Jensen BR; Parving HH
Kidney Int; 1995 Jun; 47(6):1726-31. PubMed ID: 7643542
[TBL] [Abstract][Full Text] [Related]
22. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
[TBL] [Abstract][Full Text] [Related]
23. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.
Mogensen CE
Br Med J (Clin Res Ed); 1982 Sep; 285(6343):685-8. PubMed ID: 6809187
[TBL] [Abstract][Full Text] [Related]
24. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
Parving HH; Hommel E; Smidt UM
BMJ; 1988 Oct; 297(6656):1086-91. PubMed ID: 3143437
[TBL] [Abstract][Full Text] [Related]
25. Hypertension in diabetes as related to nephropathy. Early blood pressure changes.
Feldt-Rasmussen B; Borch-Johnsen K; Mathiesen ER
Hypertension; 1985; 7(6 Pt 2):II18-20. PubMed ID: 3878333
[TBL] [Abstract][Full Text] [Related]
26. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
27. Is antihypertensive treatment the same for NIDDM and IDDM patients?
Parving HH
Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
[TBL] [Abstract][Full Text] [Related]
28. Uncontrolled hypertension is associated with a rapid progression of nephropathy in type 2 diabetic patients with proteinuria and preserved renal function.
Baba T; Murabayashi S; Tomiyama T; Takebe K
Tohoku J Exp Med; 1990 Aug; 161(4):311-8. PubMed ID: 2256104
[TBL] [Abstract][Full Text] [Related]
29. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
Parving HH; Hommel E; Jensen BR; Hansen HP
Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
[TBL] [Abstract][Full Text] [Related]
30. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Rossing P; Hommel E; Smidt UM; Parving HH
Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
[TBL] [Abstract][Full Text] [Related]
31. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.
Mogensen CE; Christensen CK; Vittinghus E
Diabetes; 1983 May; 32 Suppl 2():64-78. PubMed ID: 6400670
[TBL] [Abstract][Full Text] [Related]
32. Glomerular dysfunction in diabetic nephropathy.
Zucchelli P; Zuccalà A; Sturani A
Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
[TBL] [Abstract][Full Text] [Related]
33. Renal function, glycemic control and perindopril in diabetic patients.
Brichard S; Ketelslegers JM; Lambert AE
Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
[TBL] [Abstract][Full Text] [Related]
34. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
Mulec H; Blohmé G; Grände B; Björck S
Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Parving HH; Rossing P; Hommel E; Smidt UM
Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
[TBL] [Abstract][Full Text] [Related]
36. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
37. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy.
Passariello N; Sepe J; Marrazzo G; De Cicco A; Peluso A; Pisano MC; Sgambato S; Tesauro P; D'Onofrio F
Diabetes Care; 1993 May; 16(5):789-95. PubMed ID: 8495620
[TBL] [Abstract][Full Text] [Related]
38. Optimal dose of losartan for renoprotection in diabetic nephropathy.
Andersen S; Rossing P; Juhl TR; Deinum J; Parving HH
Nephrol Dial Transplant; 2002 Aug; 17(8):1413-8. PubMed ID: 12147788
[TBL] [Abstract][Full Text] [Related]
39. Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.
Jerums G; Allen TJ; Gilbert RE; Hammond J; Cooper ME; Campbell DJ; Raffaele J
J Diabetes Complications; 1995; 9(4):308-14. PubMed ID: 8573754
[TBL] [Abstract][Full Text] [Related]
40. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
